ZP
LLY icon

Zimmer Partners’s Eli Lilly LLY Stock Holding History

Zimmer Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-48,300
Closed -$36.9M – 148
2025
Q3 		$36.9M Sell
48,300
-2,107
-4% -$1.57M 0.8% 32
2025
Q2 		$39.3M Buy
+50,407
New +$39.2M 0.85% 29
2024
Q4 		– Sell
-6,450
Closed -$5.71M – 163
2024
Q3 		$5.71M Sell
6,450
-23,760
-79% -$21.4M 0.1% 104
2024
Q2 		$27.4M Buy
30,210
+5,310
+21% +$4.25M 0.5% 39
2024
Q1 		$19.4M Buy
+24,900
New +$17.7M 0.41% 46
2023
Q1 		– Sell
-5,000
Closed -$1.83M – 109
2022
Q4 		$1.83M Buy
+5,000
New +$1.77M 0.04% 75

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Zimmer Partners's LLY Position: Q4 2025 in Review

Zimmer Partners sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 48,300 shares — an estimated $36.9M sold.

Zimmer Partners first reported a position in LLY in Q4 2022 and held it in 6 quarters. The position peaked at $39.3M in Q2 2025. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Zimmer Partners reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Zimmer Partners sold 48,300 Eli Lilly shares in Q4 2025, an estimated $36.9M.
  • Zimmer Partners first reported a position in Eli Lilly in Q4 2022 and held it in 6 quarters.
  • Zimmer Partners's Eli Lilly position peaked at $39.3M in Q2 2025.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Zimmer Partners's 13F filing for Q4 2025, filed 17 Feb 2026.